该来源暂未提供可供站内阅读的正文
你可以阅读上方摘要，或通过下方链接访问原始报道。
OpenAI acquires Orchestra Bio
Overview
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
READ THE ORIGINAL
Read the original for the full context.
The content of this article comes from OpenAI，Copyright belongs to the original author and publisher.
Read the original ↗SSCI brings together public reporting. Refer to the original source for the full context.Feedback about content issues or request corrections
Discussion
THE CONVERSATIONDiscuss the facts and ideas with respect. Comments appear after moderation.
Loading comments…